irasia.com


Mesoblast Limited

Corporate Information

Company Name Mesoblast Limited
Registered Office (Effective from 12 January 2012)
Level 39
55 Collins Street
Melbourne VIC 3000

Telephone (61) 3 9639 6036
Facsimile (61) 3 9639 6030
Principal Place of Business Level 39
55 Collins Street
Melbourne VIC 3000

Telephone (61) 3 9639 6036
Facsimile (61) 3 9639 6030
Sector Life Science / Bio-Technology / Medical / Pharmaceutical
GICS Industry Group Pharmaceuticals / Biotechnology & Life Sciences
Internet Homepage Address (URL) http://www.mesoblast.com
Email Address info@mesoblast.com
Financial Year End June 30
Board of Directors Mr Brian Jamieson (Non-Executive Chairman, Non-Executive Director)
Mr Donal O'Dwyer (Deputy Chairman, Non-Executive Director)
Professor Silviu Itescu (CEO, Managing Director)
Mr Michael Spooner (Non-Executive Director)
Mr J. Kevin Buchi (Non-Executive Director)
Mr Byron McAllister (Non-Executive Director) (Resigned on 29 November 2010)
Management Team Mr Paul Rennie, BSc, MBM, MS (Chief Operating Officer)
Dr Suzanne Lipe BSc (Hons), PhD, LLB (Vice President, Operations)
Ms Jenni Pilcher CA, BBS (Chief Financial Officer & Company Secretary) (Appointed as Company Secretary on 1 January 2012)
Dr Donna L. Skerrett, MD, MS (Clinical and Regulatory Affairs)
Professor Peter Ghosh, BSc (Hons), PhD, DSc, FRACI, FRSC, CSc. (Vice President for Cartilage Regenerative Programs)
Ms Julie Meldrum (Corporate Communications Director)

Mr Kevin Hollingsworth, FCPA, FCMA (Company Secretary) (Resigned on 1 January 2012)
Company Secretary Jenni Pilcher
Investor Relations Contact Julie Meldrum
Principal Bankers National Australia Bank Ltd
221 Drummond Street
Carlton VIC 3053
Auditors PKF Chartered Accountants
Level 14
140 William Street
MELBOURNE VIC 3000
Solicitors Middletons Lawyers
Level 25, Rialto Tower
525 Collins Street
MELBOURNE VIC 3000
Share Registry Link Market Services Limited
Level 1
333 Collins Street
Melbourne VIC 3000
ASX Stock Code MSB
S&P/ASX 200 Index Included in S&P/ASX 200 Index on 27 April 2011
Shares on Issue 280 million (as of 9 November 2011)
Market Capitalisation US$1,870 million (as of 12 January 2012)
(A$2,300 million as of 9 November 2011)
(A$2,008 million as of 24 August 2011)
(A$1,575 million as of 9 February 2011)
(A$455 million as of 12 May 2010)
(A$282 million as of 13 January 2010)
MSB Ownership
(as of 12 January 2012)
90% - Institutions and sophisticated investors
10% - Retail
Cash at Hand US$260 million (approx) (as of 12 January 2012)
ACN 109 431 870
Listing Date 16 December 2004
ABN 68 109 431 870
ADR MBLTY

updated 9th February, 2012


  • Company's Index
  • irasia.com

  • © Copyright 1996-2012 irasia.com Ltd. All rights reserved.
    DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd be liable for damages resulting from the use of the information provided on this website.
    TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited.
    TERMS OF USE: Please read the Terms of Use governing the use of our website.